Bio-Techne (TECH) Gross Profit (2009 - 2026)

Bio-Techne has reported Gross Profit for 18 years, with the latest figure at $208.3 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 2.92% year-over-year to $208.3 million; the trailing twelve-month figure through Mar 2026 stood at $786.5 million (down 1.05% YoY), and the FY2025 full-year result was $790.3 million, up 2.67% from the prior year.
• Gross Profit for Q1 2026 stood at $208.3 million, up from $191.3 million in the prior quarter.
• The five-year high for Gross Profit was $214.6 million in Q1 2025, with the low at $176.6 million in Q4 2023.
• Average Gross Profit over 5 years is $195.3 million, with a median of $198.8 million recorded in 2025.
• Year-over-year, Gross Profit increased 19.72% in 2022 and fell 3.69% in 2023.
• Tracing TECH's Gross Profit over 5 years: stood at $183.4 million in 2022, then retreated by 3.69% to $176.6 million in 2023, then rose by 9.8% to $193.9 million in 2024, then fell by 1.35% to $191.3 million in 2025, then grew by 8.89% to $208.3 million in 2026.
• The last three Gross Profit figures came in at $208.3 million (Q1 2026), $191.3 million (Q4 2025), and $188.1 million (Q3 2025), per Business Quant data.

Peer Comparison